Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Devices is a leading provider of high-performance bioanalytical measurement systems, software, and consumables for life science research, pharmaceutical, and biotherapeutic development. The company's extensive portfolio includes industry-standard products for microplate reading, high-content imaging, and automated cell line development, such as the SpectraMax and ImageXpress series. By automating complex laboratory workflows, Molecular Devices enables scientists to accelerate drug discovery and improve the efficiency of biological research across various applications including cell biology and protein analysis. Headquartered in Silicon Valley, the company operates as a key part of Danaher Corporation's Life Sciences segment, serving customers in academic, government, and biotech sectors globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Devices.